- Advertisement -

Psychedelic-Like Drug Lacking Hallucinogenic Side Effects Identified with New Sensor

At the University of California (UC), Davis, psychLight just dropped in to see what condition serotonin dynamics was in. And psychLight didn’t even have...

Bacteria engineered for remote sensing through color signatures

Bacteria can be engineered to sense a variety of molecules, such as pollutants or soil nutrients. In most cases, however, these signals can only...

Congress urged to strengthen PH’s biotechnology center to ensure food security – Manila Bulletin

Published December 2, 2019, 7:56 AM By Charissa Luci-Atienza Instead of creating another agency that would rationalize the regulation of modern biotechnology in the country,...

Lyndra Therapeutics Signs Manufacturing Agreement with Thermo for Long-Acting Oral Therapies

Lyndra Therapeutics, a clinical-stage biopharma firm, entered into a strategic collaboration with Thermo Fisher Scientific in which Thermo will provide global clinical research and...

LIXT Stock: 8 Things to Know About Lixte Biotechnology As Shares...

Lixte Biotechnology (NASDAQ:LIXT) stock is heading higher on Friday despite a lack of news concerning the company. Source: Shutterstock The rise in price...

First investigational drug therapy for liver disease NASH awaiting FDA approval

Global clinical trial designed in collaboration with VCU successfully tested a drug therapy to treat NASH, a chronic liver disease and the fastest-growing reason...

Beyond the Technology: AI Readiness in Regulated Laboratories

Artificial intelligence readiness involves much more than upgrading technology. For laboratories operating in regulated environments, it requires connected workflows, trusted data, effective human oversight,...

Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow...

Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow. Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply...

Beyond the Technology: AI Readiness in Regulated Laboratories

Artificial intelligence readiness involves much more than upgrading technology. For laboratories operating in regulated environments, it requires connected workflows, trusted data, effective human oversight,...

Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow for Difficult Therapeutic...

Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow. Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply...

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors for Huntington’s

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...

more new items

Beyond the Technology: AI Readiness in Regulated Laboratories

Artificial intelligence readiness involves much more than upgrading technology. For laboratories operating in regulated environments, it requires connected workflows, trusted data, effective human oversight,...

Receptor.AI and Sethera Plan to Create Closed-Loop Discovery and Optimization Workflow...

Receptor.AI and Sethera partner to create a closed-loop drug discovery workflow. Sethera will generate and experimentally screen architecture-diverse polymacrocyclic peptide libraries. Receptor.AI will apply...

Axiom’s Hong Kong Bet, Latigo’s Positive Phase II, and Base Editors...

In the business news section of this week’s episode, Axiom Biosciences recently announced its plans to go public and made headlines for its plans...